A Combination Study of Rucaparib and Atezolizumab in Participants With Advanced Gynecologic Cancers and Triple-Negative Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Gynecologic Neoplasms
Interventions: DRUG: Atezolizumab|DRUG: Rucaparib
Sponsor: Hoffmann-La Roche